No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: The Alpha Omega Trial

International Journal of Andrology

Volumn 35, Issue 5, 2012, Pages 680-687

  Giltay, E J ^a   Geleijnse, J M ^b   Heijboer, A C ^c   de Goede, J ^b   Oude Griep, L M ^b   Blankenstein, M A ^c   Kromhout, D ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alpha linolenic acid; Docosahexaenoic acid; Eicosapentaenoic acid; N 3 polyunsaturated fatty acids; Testosterone

Indexed keywords

DOCOSAHEXAENOIC ACID; LINOLENIC ACID; MARGARINE; OMEGA 3 FATTY ACID; TESTOSTERONE;

ADULT; AGED; ANDROGEN DEFICIENCY; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

AGED; AGED, 80 AND OVER; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; HUMANS; MALE; MARGARINE; MIDDLE AGED; MYOCARDIAL INFARCTION; TESTOSTERONE;

EID: 84866165755     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2012.01255.x     Document Type: Article

References (41)

1. Akaza H, Hinotsu S, Usami M, Arai Y, Kanetake H, Naito S & Hirao Y. (2009) Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival. Cancer 115, 3437-3445.
2. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT & Wittert GA. (2011) Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 96, 3007-3019.
3. Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, Willett WC & Giovannucci E. (2003) A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev 12, 64-67.
4. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH & van der Schouw YT. (2011) Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol 40, 189-207.
5. Brouwer IA, Katan MB & Zock PL. (2004) Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 134, 919-922.
6. Bui HN, Struys EA, Martens F, de Ronde W, Thienpont LM, Kenemans P, Verhoeven MO, Jakobs C, Dijstelbloem HM & Blankenstein MA. (2010) Serum testosterone levels measured by isotope dilution-liquid chromatography-tandem mass spectrometry in postmenopausal women versus those in women who underwent bilateral oophorectomy. Ann Clin Biochem 47, 248-252.
7. Dandona P & Dhindsa S. (2011) Hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab 96, 2643-2651.
8. DeStefani E, Deneo-Pellegrini H, Boffetta P, Ronco A & Mendilaharsu M. (2000) Alpha-linolenic acid and risk of prostate cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev 9, 335-338.
9. Elmadfa I & Kornsteiner M. (2009) Fats and fatty acid requirements for adults. Ann Nutr Metab 55, 56-75.
10. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL & Stampfer MJ. (1994) Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86, 281-286.
11. Geleijnse JM, Giltay EJ, Schouten EG, de Goede J, Oude Griep LM, Teitsma-Jansen AM, Katan MB & Kromhout D. (2010) Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4, 837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial. Am Heart J 159, 539-546.
12. Giltay EJ, Geleijnse JM, Schouten EG, Katan MB & Kromhout D. (2003) High stability of markers of cardiovascular risk in blood samples. Clin Chem 49, 652-655.
13. Giltay EJ, Duschek EJ, Katan MB, Zock PL, Neele SJ & Netelenbos JC. (2004a) Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women. J Endocrinol 182, 399-408.
14. Giltay EJ, Gooren LJG, Toorians AWFT, Katan MB & Zock PL. (2004b) Levels of docosahexaenoic acid are higher in women than in men through estrogenic effects. Am J Clin Nutr 80, 1167-1174.
15. Gromadzka-Ostrowska J. (2006) Effects of dietary fat on androgen secretion and metabolism. Reprod Biol 6(Suppl 2), 13-20.
16. Haring R, Volzke H, Steveling A, Krebs A, Felix SB, Schofl C, Dorr M, Nauck M & Wallaschofski H. (2010) Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 31, 1494-1501.
17. Harman SM, Metter EJ, Tobin JD, Pearson J & Blackman MR. (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86, 724-731.
18. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE & Vatten L. (1997) Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 71, 545-551.
19. Hughes GS, Ringer TV, Watts KC, DeLoof MJ, Francom SF & Spillers CR. (1990) Fish oil produces an atherogenic lipid profile in hypertensive men. Atherosclerosis 84, 229-237.
20. Jones TH. (2010) Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol Metab 21, 496-503.
21. Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ & Saad F. (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blind placebo-controlled Moscow study. Clin Endocrinol (Oxf) 73, 602-612.
22. Kaufman JM & Vermeulen A. (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26, 833-876.
23. Kromhout D, Giltay EJ & Geleijnse JM. (2010) n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363, 2015-2026.
24. Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, Willett WC & Giovannucci EL. (2004) Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 80, 204-216.
25. Léon H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T & Tsuyuki RT. (2008) Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 337, a2931.
26. Malkin CJ, Pugh PJ, Morris PD, Asif S, Jones TH & Channer KS. (2010) Low serum testosterone and increased mortality in men with coronary heart disease. Heart 96, 1821-1825.
27. Nagata C, Takatsuka N, Kawakami N & Shimizu H. (2000) Relationships between types of fat consumed and serum estrogen and androgen concentrations in Japanese men. Nutr Cancer 38, 163-167.
28. Newcomer LM, King IB, Wicklund KG & Stanford JL. (2001) The association of fatty acids with prostate cancer risk. Prostate 47, 262-268.
29. Norrish AE, Skeaff CM, Arribas GL, Sharpe SJ & Jackson RT. (1999) Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study. Br J Cancer 81, 1238-1242.
30. Oh JY, Barrett-Connor E, Wedick NM & Wingard DL. (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25, 55-60.
31. Phelan N, O'Connor A, Kyaw TT, Correia N, Boran G, Roche HM & Gibney J. (2011) Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial. Am J Clin Nutr 93, 652-662.
32. Roddam AW, Allen NE, Appleby P & Key TJ. (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100, 170-183.
33. Rose DP. (1997) Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr 66, 1513S-1522S.
34. Stellato RK, Feldman HA, Hamdy O, Horton ES & McKinlay JB. (2000) Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23, 490-494.
35. Svartberg J, von Mühlen D, Sundsfjord J & Jorde R. (2004) Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol 19, 657-663.
36. Terry P, Lichtenstein P, Feychting M, Ahlbom A & Wolk A. (2001) Fatty fish consumption and risk of prostate cancer. Lancet 357, 1764-1766.
37. Vargas ML, Almario RU, Buchan W, Kim K & Karakas SE. (2011) Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism 60, 1711-1718.
38. Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ et al. (2009) ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 12, 5-12.
39. Wathes DC, Abayasekara DR & Aitken RJ. (2007) Polyunsaturated fatty acids in male and female reproduction. Biol Reprod 77, 190-201.
40. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW et al. (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93, 2737-2745.
41. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD et al. (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363, 123-135.